The Tendyne system replaces mitral valves that are not functioning properly due to a buildup of calcium in the base of the valves, known as severe mitral annular calcification (MAC) Tendyne offers ...

The FDA has approved the company’s Tendyne system, as a minimally invasive heart replacement for patients with mitral valve disease that would otherwise make them ineligible for the top-selling ...

The Tendyne system is designed for those who are considered high-risk for traditional open-heart surgery and for whom mitral valve repair with Abbott’s MitraClip is not a viable option.

Abbott Laboratories ABT has recently received Food and Drug Administration (“FDA”) approval for its Tendyne transcatheter mitral valve replacement (“TMVR”) system. The Tendyne system ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR) system.

The US Food and Drug Administration has approved the Tendyne transcatheter mitral valve replacement (TMVR) system for the treatment of patients with mitral valve dysfunction, device manufacturer ...

The Tendyne system is designed for those who are considered high-risk for traditional open-heart surgery and for whom mitral valve repair with Abbott’s MitraClip is not a viable option. The FDA’s ...

May 27, 2025 /PRNewswire/ -- Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat ...